STOCK TITAN

Zentek Ltd SEC Filings

ZTEK NASDAQ

Welcome to our dedicated page for Zentek SEC filings (Ticker: ZTEK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

The Zentek Ltd. (ZTEK) SEC filings page on Stock Titan provides access to the company’s U.S. regulatory disclosures, primarily furnished on Form 6-K as a foreign private issuer and linked to its Form 40-F and Form F-3 registration statement. These filings supply official documentation that complements Zentek’s press releases on technology, operations and governance.

Recent Form 6-K reports incorporate a range of exhibits, including press releases on Albany Graphite Corp.’s ultra-high purity graphite testing for nuclear and lithium-ion battery applications, the development of a Graphite Gel-Based Fire-Retardant product and related U.S. licensing agreement with Altek Advanced Materials Inc., and updates on ZenGUARD™ Enhanced Air Filters, corporate strategy and international commercialization efforts. Other 6-K filings attach unaudited condensed interim consolidated financial statements, Management’s Discussion and Analysis, and certifications of interim filings by Zentek’s senior officers.

Filings also cover corporate events such as CEO appointments, annual and special meeting voting results, omnibus long-term incentive plan approvals and responses to tax reassessment matters, all documented through exhibits to Form 6-K. For investors tracking Zentek’s advanced materials and healthcare technology activities, these filings provide the formal record of milestones first announced in news releases.

On Stock Titan, users can review these SEC submissions alongside AI-powered summaries that highlight key points from each document, helping to interpret technical content and multi-exhibit reports more efficiently. This includes quick views of technology-related disclosures, governance decisions and financial reporting contained in Zentek’s 6-Ks and other incorporated filings, updated as new documents are furnished to the EDGAR system.

Rhea-AI Summary

Zentek Ltd. filed a Form 6-K as a foreign private issuer, signed by its Chief Financial Officer, Wendy Ford. The filing notes that an exhibit is attached: a press release dated November 21, 2025, titled "Zentek Receives CRA Notice of Reassessment for 2019." This indicates the company has received a tax reassessment notice from the Canada Revenue Agency relating to its 2019 tax year, and is informing investors through the attached press release.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.69%
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Zentek Ltd. submitted a Form 6-K for November 2025 that mainly forwards a press release about a new product and licensing arrangement. The exhibit notes that Zentek has developed a new graphite gel-based fire-retardant product and entered into an exclusive licence with Altek Advanced Materials Inc. for the United States market. This filing formally records that product development and exclusive U.S. licensing step for investors.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.3%
Tags
current report
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.42%
Tags
current report
-
Rhea-AI Summary

Zentek Ltd. submitted a Form 6-K as a foreign private issuer for September 2025. The filing is signed by Chief Financial Officer Wendy Ford on behalf of the company. It furnishes two exhibits: a report of voting results dated September 25, 2025 and a press release dated the same day announcing the voting results of Zentek's annual and special meeting. These materials provide details on how shareholders voted on the matters presented at that meeting.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.4%
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.44%
Tags
current report
Rhea-AI Summary

Zentek Ltd. filed a Form 6-K as a foreign private issuer. The filing mainly serves as a cover to furnish an attached press release as an exhibit.

The exhibit, dated September 18, 2025, provides a preliminary update on Zentek’s influenza countermeasure candidate developed using its multivalent aptamer technology against H1N1 seasonal influenza.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.02%
Tags
current report
-
Rhea-AI Summary

Zentek Ltd. filed an amended Form 6-K to update materials for its 2025 Annual and Special Meeting of Shareholders scheduled for September 25, 2025. The amendment furnishes a revised form of proxy, an amended voting instruction form, a letter to shareholders, and a supplement to the management information circular, all intended to guide how shareholders vote at the meeting.

The company also includes a press release announcing new board nominees and re-attaches the original notice of meeting and management information circular and related notice-and-access documents. Certain updated meeting materials are incorporated by reference into Zentek’s effective shelf registration statement on Form F-3, making them part of the disclosure record for potential future securities offerings under that registration.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.12%
Tags
current report
-
Rhea-AI Summary

Zentek Ltd. filed a Form 6-K as a foreign private issuer to furnish information for September 2025. The filing primarily forwards two press releases as exhibits. One press release announces the resignation of the company’s CEO, who is named as Greg Fenton, and notes that he will take a new strategic leadership role in a U.S.-based venture. The second press release details changes to Zentek’s board of directors and updates to board nominations for the upcoming annual and special meeting of shareholders. The report is signed on behalf of Zentek by Chief Financial Officer Wendy Ford.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Summary

Zentek Ltd., a foreign private issuer, filed a Form 6-K for September 2025. The filing attaches a press release noting that its subsidiary, Albany Graphite Corp., was awarded a $500,000 Critical Minerals Innovation Fund grant for a purification and anode development project.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.4%
Tags
current report

FAQ

What is the current stock price of Zentek (ZTEK)?

The current stock price of Zentek (ZTEK) is $0.628 as of March 13, 2026.

What is the market cap of Zentek (ZTEK)?

The market cap of Zentek (ZTEK) is approximately 68.8M.

ZTEK Rankings

ZTEK Stock Data

68.82M
101.61M
Medical Instruments & Supplies
Healthcare
Link
Canada
Guelph

ZTEK RSS Feed